Characterisation of T Cell Receptor Repertoire in Non-small Cell Lung Cancer Patients Treated with Immunotherapy

被引：0
作者：
Goni, A. S. [1 ]
Ramirez, A. [2 ]
Cruellas, M. [3 ]
Esteban, P. [2 ]
Galvez, E. M. [4 ]
Gascon-Ruiz, M. [5 ]
Isla, D. [5 ]
Martinez-Lostao, L. [2 ]
Ocariz, M. [5 ]
Pano, J. R. [5 ]
Pardo, J. [2 ]
Quilez, E. [5 ]
Torres-Ramon, I. [5 ]
Yubero, A. [5 ]
Zapata, M. [5 ]
Lastra, R. [5 ]
机构：
[1] Hosp Clin Univ Lozano Blesa, Zaragoza, Spain
[2] Aragon Hlth Res Inst, Zaragoza, Spain
[3] Hosp Valle De Hebron, Barcelona, Spain
[4] CSIC, Inst Carboquim, Zaragoza, Spain
[5] Hosp Clin Lozano Blesa, Zaragoza, Spain
来源：
JOURNAL OF THORACIC ONCOLOGY | 2022年 / 17卷 / 09期
关键词：
LUNG CANCER; BIOMARKER; T-CELL RECEPTOR;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP16.01-03
引用
收藏
页码：S570 / S571
页数：2
相关论文
共 50 条
  • [31] Evaluation of Combined Biomarker of Response to Immunotherapy in Patients with Advanced Non-Small Cell Lung Cancer
    Ramdani, H.
    Falk, M.
    Schatz, S.
    Heukamp, L.
    Tiemann, M.
    Wesseler, C.
    Schuuring, E.
    Groen, H.
    Griesinger, F.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S413 - S414
  • [32] Immune Checkpoint Inhibitor Score Predicts Survival Benefit of Immunotherapy in Patients with Non-small Cell Lung Cancer
    Kang, Da Hyun
    Choi, Chang-Min
    Park, Cheol-Kyu
    Oh, In-Jae
    Kim, Young-Chul
    Yoon, Seong Hoon
    Kim, Yoonjoo
    Lee, Jeong Eun
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2024, 87 (04) : 483 - 493
  • [33] The performance status gap in immunotherapy for frail patients with advanced non-small cell lung cancer
    Wu, Julie Tsu-Yu
    Corrigan, June
    Su, Chloe
    Dumontier, Clark
    La, Jennifer
    Khan, Aparjita
    Arya, Shipra
    Harris, Alex H. S.
    Backhus, Leah
    Das, Millie
    Do, Nhan V.
    Brophy, Mary T.
    Han, Summer S.
    Kelley, Michael
    Fillmore, Nathanael R.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 73 (09)
  • [34] Efficacy and safety analysis of immunotherapy in non-small cell lung cancer patients with MET alterations
    Wang, Yanhua
    Wei, Jingwen
    Xu, Manyi
    Xiang, Jing
    Shao, Keda
    Hao, Yue
    Song, Zhengbo
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (10) : 2503 - 2512
  • [35] Impact of antibiotics, corticosteroids, and microbiota on immunotherapy efficacy in patients with non-small cell lung cancer
    Zapata-Garcia, Maria
    Moratiel-Pellitero, Alba
    Isla, Dolores
    Galvez, Eva
    Gascon-Ruiz, Marta
    Sesma, Andrea
    Barbero, Raquel
    Galeano, Javier
    del Campo, Rosa
    Ocariz, Maitane
    Quilez, Elisa
    Cruellas, Mara
    Pardo, Julian
    Martinez-Lostao, Luis
    Domingo, Maria Pilar
    Esteban, Patricia
    Torres-Ramon, Irene
    Yubero, Alfonso
    Pano, Jose Ramon
    Lastra, Rodrigo
    HELIYON, 2024, 10 (13)
  • [36] Sequencing of T cell Receptor Revealed Radiotherapeutic Efficacy and Prognosis in Non-small Cell Lung Cancer Patients with Brain Metastasis
    Zeng, H.
    Dong, X.
    Tong, F.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S498 - S498
  • [37] The emerging role of T cell cytokines in non-small cell lung cancer
    Neurath, Markus F.
    Finotto, Susetta
    CYTOKINE & GROWTH FACTOR REVIEWS, 2012, 23 (06) : 315 - 322
  • [38] Dynamic Monitoring of Immunotherapy Effectiveness with Different Biomarkers in the Patients with Non-Small Cell Lung Cancer
    Ganesh, Sridha
    Wang, Rui
    Chen, Honglei
    ONCOLOGIE, 2021, 23 (03) : 335 - 350
  • [39] Immunotherapy in the landscape of new targeted treatments for non-small cell lung cancer
    Gerard, Catherine
    Debruyne, Channa
    MOLECULAR ONCOLOGY, 2009, 3 (5-6) : 409 - 424
  • [40] Implementation of immunotherapy in the treatment of advanced non-small cell lung cancer (NSCLC)
    Tsiara, Anna
    Liontos, Michalis
    Kaparelou, Maria
    Zakopoulou, Roubini
    Bamias, Aristotelis
    Dimopoulos, Meletios-Athanasios
    ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6 (08)
12345